Foley Hoag LLP

WHEN

October 19 6:00 PM - October 22, 2008 12:30 PM

WHERE

Washington State Convention & Trade Center
800 Convention Place
Seattle, WA 98101

Map

SUMMARY

Foley Hoag is a proud Gold Sponsor of the ACC's 2008 Annual Meeting. Visit our booth on the exhibition floor, and attend sessions featuring Foley Hoag lawyers.

• Session 113: In-house Counsel as Circus Ringmaster, on Monday, October 20 from 11:00 a.m.-12:30 p.m. Michael Keating from Foley Hoag will join this panel in the Global/International Legal Affairs program track.
• Session 202: The Tricks & Traps of Corporate Intrapreneurship & Entrepreneurial Investment: Getting the Most Out of a New Business, on Monday, October 20 from 2:30-4:00 p.m. This program will be moderated by Foley Hoag Partner Peter Rosenblum and will be presented as part of the Small Law Department track. 

Stay tuned to this page for more information on what Foley Hoag has planned for ACC's 2008 Annual Meeting.

WHEN

October 22, 2008 8:30 AM - 11:00 AM

WHERE

The Conference Center at WilmerHale
60 State Street
Boston, MA

Map

SUMMARY

The Boston Patent Law Association (BPLA) Patent Law Committee invites you to attend a seminar focusing on the ever changing standard of what constitutes inequitable conduct in practice before the Patent Office. This seminar will be held on Wednesday, October 22, 2008 at  the Conference Center at WilmerHale in Boston.

WHEN

October 28, 2008 7:30 AM - 9:30 AM

WHERE

Emerging Enterprise Center at Foley Hoag
Bay Colony Corporate Center, North Entrance
1000 Winter Street - Suite 4000
Waltham, MA 02451

Map

SUMMARY

So you are ready to sell your privately held business. As if the issues raised by the current credit crisis were not enough, you will also have to grapple with the ever present complex web of governance issues that arise in these types of transactions:

• differences among major stockholders and/or members of the Board of Directors regarding proper direction and strategy for the business
• divergent views among different constituencies about value
• differing stockholder needs for liquidity and views about exit timing
• different perceptions generally between active and passive stockholders

Join us on October 28 when Cronus Partners will host a panel discussion regarding these topics, including a case study of a recently completed transaction that presented these issues.

Speakers:
Alan Canzano, Managing Director, Cronus Partners LLC
Michael Blanco, Chief Executive Officer, Resolute Partners, LLC
Reggie Babcock, Managing Director, Endeavour Advisors, LLC
Craig Hoffman, President, Bill Blass

WHEN

November 6, 2008 5:30 PM - 8:00 PM

WHERE

Foley Hoag LLP (Boston Office)
Seaport World Trade Center West
155 Seaport Boulevard
Boston, MA 02210-2600

Map

SUMMARY

Are you an entrepreneur wanting to learn more about navigating New England’s business and funding landscape? Are you an investor seeking to mentor and become even more integrated in New England’s entrepreneurial community? Save this date to bring your ideas to a (free) networking event with entrepreneurial experts!

WHEN

November 12 7:30 AM - November 13, 2008 3:00 PM

WHERE

Helmsley Park Lane Hotel
36 Central Park S
New York, NY 10019

Map

SUMMARY

With pipelines drying up, patent expirations at an all time high and R&D costs through the roof, the stakes in negotiating and maintaining lucrative licensing and collaborations could not be higher. But as the critical nature of these deals increases, so do the challenges and complexities.

Competition is increasing, laws are changing, and M&A activity is heating up. Further, IP valuation contingencies are arising in the wake of the Supreme Court's MedImmune decision, and parties are seeking greater protection for their IP rights and looking to draft termination provisions that allow both parties to walk away with their assets intact. In addition, selecting the right partners, deal structure and compensation analysis are crucial to the success of the deal, and an assessment of these factors must be done early in the process. Lastly, as biotech/pharma look more and more to collaborate with the government and institutional researchers for a competitive edge, they face a distinct culture clash that leads to wheel-spinning, preventing agreements from being reached.

Unlike any other licensing event, you will not only get the opportunity to network with and learn from a diverse, front-line faculty of experienced in-house counsel, licensing and business development executives from leading pharmaceutical and biotech companies, but you will also receive practical guidance on how to translate new laws and trends into a winning business strategy and overcome challenges and complexities in negotiating and maintaining the best deal available for your company's needs.